SEC Comment Letter for Rezolute, Inc. (RZLT) (CIK 0001509261) (RZLT) — Oct 13, 2017
Rezolute, Inc. (RZLT) (CIK 0001509261)
Date: Oct. 13, 2017 · CIK: 0001509261 · Accession: 0000000000-17-036357
AI Filing Summary & Sentiment
Reasoning
Letter
October 13, 2017 Hoyoung Huh Secretary AntriaBio, Inc. 1450 Infinite Drive Louisville, CO 80027 AntriaBio, Inc. Preliminary Proxy Statement on Schedule 14A Filed September 27, 2017 File No. 000-54495Re: Dear Dr. Huh: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
October 13, 2017 Hoyoung Huh Secretary AntriaBio, Inc. 1450 Infinite Drive Louisville, CO 80027 AntriaBio, Inc. Preliminary Proxy Statement on Schedule 14A Filed September 27, 2017 File No. 000-54495Re: Dear Dr. Huh: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance